TrialBMJ open2016

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.

Agnihotram V Ramanakumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.